Molecular Defects in Cardiovascular Disease
(Sprache: Englisch)
Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics. Divided into three...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
164.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Molecular Defects in Cardiovascular Disease “
Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics. Divided into three sections, this book covers the scientific foundations of our present understanding as well as the array of clinical manifestations and their treatment. The first section covers Molecular Mechanisms of Heart Disease, with discussion of the development of cardiovascular dysfunction. The remaining two sections provide a more clinical focus. The second, Cardiac Hypertrophy and Heart Failure deals with metabolic derangements, Ca2+ handling, and subcellular remodeling. It illustrates the wide variety of molecular defects which may serve as targets associated with the transition from cardiac hypertrophy to advanced heart failure. The third section, Hypertension and Diabetes, provides molecular rationale for the pathogenesis of hypertension and diabetic cardiomyopathy, as well as highlighting the importance of hormones toward this end.
A necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology. It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies.
A necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology. It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies.
Klappentext zu „Molecular Defects in Cardiovascular Disease “
Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics. Divided into three sections, this book covers the scientific foundations of our present understanding as well as the array of clinical manifestations and their treatment. The first section covers Molecular Mechanisms of Heart Disease, with discussion of the development of cardiovascular dysfunction. The remaining two sections provide a more clinical focus. The second, Cardiac Hypertrophy and Heart Failure deals with metabolic derangements, Ca2+ handling, and subcellular remodeling. It illustrates the wide variety of molecular defects which may serve as targets associated with the transition from cardiac hypertrophy to advanced heart failure. The third section, Hypertension and Diabetes, provides molecular rationale for the pathogenesis of hypertension and diabetic cardiomyopathy, as well as highlighting the importance of hormones toward this end. A necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology. It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies.
Inhaltsverzeichnis zu „Molecular Defects in Cardiovascular Disease “
A. Molecular Mechanisms in Heart Disease1. Calcium overloading-induced oxidative stress-mediated cellular and subcellular remodeling
Y. Cheema, A.U. Shahbaz, S.K. Bhattacharya, R.A. Ahokas, Y.Sun, I.C. Gerling and K.T. Weber
2. Intracellular MMP-2: Role in normal and diseased hearts
N. Youssef and R. Schulz
3. Control of the mesenchymal-derived cell phenotype by Ski and Meox2: A putative mechanism for post-developmental phenoconversion
R.H. Cunnington, J.T. Wigle, J.M. Douville, D.H. Freed, D. Schaafsma, S. O'Connor, S. Gupta, S.G. Rattan, A. Halayko and I.M.C. Dixon
4. Elevated Na+/H+ exchanger expression and its role in myocardial disease
L. Fliegel
5. Impact of perinatal chronic hypoxia on cardiac tolerance to acute ischemia
B. Ostadal, I. Ostadalova, F. Kolar, I. Netuka, O. Szarszoi,
6. Stem cell, microRNA and redox cycling
P. Mukhopadhay, N. Gurusamy and D.K. Das
7. Cardiac cell therapy: Present and future
D.K. Singla
B. Cardiac Hypertophy and Heart Failure
8. Macroscopic and microscopic aspects of cardiac dysfunction in congestive heart failure
H.E.D.J. ter Keurs
9. Cardiac dysfunction and metabolism: Unravelling the molecular cross-talk
V. Sharma and J.H. McNeill
10. Metabolic remodeling of the hypertrophied heart
J.M. Dai and M.F. Allard
11. Mechanisms for the regulation of phospholipase C gene expression in cardiac hypertrophy
P.S. Tappia
12. Molecular changes in fatty acid oxidation in the failing heart
J.S. Jaswal, W. Keung, W. Wang, J.R. Ussher and G.D. Lopaschuk
13. Cardiolipin metabolism in experimental and human heart failure
... mehr
G.M. Hatch
14. Mechanisms underlying development of cardiomyocyte hypertrophy via Na-H exchange stimulation
M. Karmazyn
15. The structural basis of cardiac dysfunction in human heart failure
S. Hein, S. Kostin and J. Schaper
16. Hormonal mechanisms of cardiac remodeling in heart failure
A.P. Babick, V. Elimban and N.S. Dhalla
17. Modulators of remodeling after myocardial infarction
B.I. Jugdutt
18. Phosphodiesterase-5 inhibitors in protection against doxorubicin-induced cardiomyopathy
S. Koka and R.C. Kukreja
C. Hypertension and Diabetes
19. Molecular basis of pulmonary hypertension in left heart failure
B. Raj, H.S. Pillai and C.C. Kartha
20. Modulation of Gi protein expression in hypertension: Molecular mechanisms
M.B. Anand-Srivastava
21. Vascular dysfunction in heart disease
R. Perrault and P. Zahradka
22. Cellular and molecular mechanisms associated with salicylate inhibition of intimal hyperplasia balloon catheter-induced vascular injury
S.N. Murthy, P.J. Kadowitz and D.B. McNamara
23. Involvement of growth factor receptor and non receptor protein tyrosine kinases in endothelin 1 and angiotensin II-induced signaling pathways in the cardiovascular system.
G. Vardatsikos and A.K. Srivastava
24. Sarco/endoplasmic reticulum Ca2+ pump damage by oxidative stress: Implications for Ca2+ entry
G. Akolkar and A.K. Grover
25. Obesity-hypertension: Leptin as the common link to cardiovascular and renal dysregulation
S. Kshatriya, H. Kozman, D. Siddiqui, L. Bhatta, K. Liu, A. Salah, T. Ford, R. Michiel, R. Carhart and D. Villarreal
26. Cardiorenal protection in diabetes mellitus
H. Vashistha, L.G. Meggs and A. Malhotra
27. Molecular mechanisms in the pathogenesis of diabetic cardiomyopathy
S. Chakrabarti
G.M. Hatch
14. Mechanisms underlying development of cardiomyocyte hypertrophy via Na-H exchange stimulation
M. Karmazyn
15. The structural basis of cardiac dysfunction in human heart failure
S. Hein, S. Kostin and J. Schaper
16. Hormonal mechanisms of cardiac remodeling in heart failure
A.P. Babick, V. Elimban and N.S. Dhalla
17. Modulators of remodeling after myocardial infarction
B.I. Jugdutt
18. Phosphodiesterase-5 inhibitors in protection against doxorubicin-induced cardiomyopathy
S. Koka and R.C. Kukreja
C. Hypertension and Diabetes
19. Molecular basis of pulmonary hypertension in left heart failure
B. Raj, H.S. Pillai and C.C. Kartha
20. Modulation of Gi protein expression in hypertension: Molecular mechanisms
M.B. Anand-Srivastava
21. Vascular dysfunction in heart disease
R. Perrault and P. Zahradka
22. Cellular and molecular mechanisms associated with salicylate inhibition of intimal hyperplasia balloon catheter-induced vascular injury
S.N. Murthy, P.J. Kadowitz and D.B. McNamara
23. Involvement of growth factor receptor and non receptor protein tyrosine kinases in endothelin 1 and angiotensin II-induced signaling pathways in the cardiovascular system.
G. Vardatsikos and A.K. Srivastava
24. Sarco/endoplasmic reticulum Ca2+ pump damage by oxidative stress: Implications for Ca2+ entry
G. Akolkar and A.K. Grover
25. Obesity-hypertension: Leptin as the common link to cardiovascular and renal dysregulation
S. Kshatriya, H. Kozman, D. Siddiqui, L. Bhatta, K. Liu, A. Salah, T. Ford, R. Michiel, R. Carhart and D. Villarreal
26. Cardiorenal protection in diabetes mellitus
H. Vashistha, L.G. Meggs and A. Malhotra
27. Molecular mechanisms in the pathogenesis of diabetic cardiomyopathy
S. Chakrabarti
... weniger
Bibliographische Angaben
- 2011, 2011, XVIII, 382 Seiten, 31 farbige Abbildungen, Maße: 18,3 x 26 cm, Gebunden, Englisch
- Herausgegeben: Naranjan S. Dhalla, Makoto Nagano, Bohuslav Ostadal
- Verlag: Springer, Berlin
- ISBN-10: 1441971297
- ISBN-13: 9781441971296
- Erscheinungsdatum: 09.08.2011
Sprache:
Englisch
Kommentar zu "Molecular Defects in Cardiovascular Disease"
Schreiben Sie einen Kommentar zu "Molecular Defects in Cardiovascular Disease".
Kommentar verfassen